RT Journal T1 NAtional cancer institute study of krebiozen JF Journal of the American Medical Association JO Journal of the American Medical Association YR 1959 FD April 11 VO 169 IS 15 SP 1759 OP 1759 DO 10.1001/jama.1959.03000320061015 UL http://dx.doi.org/10.1001/jama.1959.03000320061015 AB The American Cancer Society statement dated March 9, 1959, which appears in this issue of The Journal, page 1790, urged that the Krebiozen Research Foundation accept the proposal of the National Cancer Institute of the U. S. Public Health Service to test the controversial cancer substance, Krebiozen, in "a manner acceptable to the scientific community." This statement reviews the history of Krebiozen; it clarifies the issues and presents the society's position regarding it.Since the Krebiozen Research Foundation, its spokesmen, and advocates have "long claimed they have a useful tool against cancer," the American Cancer Society indicated that "it is then their clear duty to thousands of cancer patients to cooperate with the National Cancer Institute or any group of competent, objective scientists in an objective test of the drug." Furthermore, the society indicated that the "delays" which have recently been given so much publicity by the Krebiozen Foundation "are